<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>513-THEOPHYLLINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="THEOPHYLLINE " rxcui="10438">
<ATC code="R03DA04" />
<ATC code="R03DB04" />
<ATC code="R03DA54" />
<ATC code="R03DA74" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="LITHIUM" rxcui="6448">
<ATC code="D11AX04" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the lithemia with risk of reduction of the therapeutic effectiveness</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Strict monitoring of the lithemia and possible adjustment of the dosage of the lithium.</COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>513-THEOPHYLLINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="THEOPHYLLINE " rxcui="10438">
<ATC code="R03DA04" />
<ATC code="R03DB04" />
<ATC code="R03DA54" />
<ATC code="R03DA74" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="PROPAFENONE" rxcui="8754">
<ATC code="C01BC03" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of increase of the theophyllinemia due to decrease of its hepatic metabolism by the propafenone</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Clinical monitoring and possibly monitoring of the theophyllinemia.</COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>513-THEOPHYLLINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="THEOPHYLLINE " rxcui="10438">
<ATC code="R03DA04" />
<ATC code="R03DB04" />
<ATC code="R03DA54" />
<ATC code="R03DA74" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="VEMURAFENIB" rxcui="1147220">
<ATC code="L01XE1" />
</DRUG>
</DRUG2>
<DESCRIPTION>Large increase of the concentrations of theophylline, with risks of increase of its undesirable effects.</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Clinical monitoring and adjustment of the dosage of the theophylline during the treatment with vemurafenib and after it is stopped. </COMMENT>
</INTERACTION>
</INTERACTIONS>
